Tracking how CF treatments work over time in Canada

Can-IMPACT CF is a long-term observational study that tracks the real-world health outcomes of people with cystic fibrosis who are receiving CFTR modulator therapy. Rather than testing a new drug, researchers will collect clinical data and patient feedback from people already receiving this treatment as part of their regular medical care. The goal is to understand how well these medications work over time and which treatments are most effective for different individuals.

CFTR modulator therapies have shown promise in treating cystic fibrosis, but doctors need to understand how these medications perform over the long term in real-world settings across Canada. By tracking patient outcomes systematically, researchers can identify which treatments work best for whom and help guide future treatment decisions.